BAUSCH HEALTH COMPAN

BHC

Delayed - 03/08 04:10:00 pm
33.08USD	+0.33%

03/09/21 \| 02:25pm	Barclays Global Healthcare Conference
04/27/21	Annual General Meeting
05/11/21	Q1 2021 Earnings Release (Projected)
08/10/21	Interim 2021 Earnings Release (Projected)

03/03/21 \| 02:00pm	JP Morgan Global High Yield & Leveraged Finance Conference
03/01/21 \| 11:00am	Cowen & Co. Health Care Conference
02/24/21 \| 08:00am	FY 2020 Earnings Call
02/24/21 \| 06:59am	FY 2020 Earnings Release

03/09/21	CURALEAF HOLDINGS, INC. : FY 2020 Earnings Release
03/09/21	ASTRAZENECA PLC : Carnegie Nordic Healthcare Seminar
03/09/21	ASTRAZENECA PLC : Barclays Global Healthcare Conference
03/09/21	ASTRAZENECA PLC : Daiwa, Investment Conference

03/08/21	ASTRAZENECA PLC : Bank of America Healthcare Bus Tour
03/06/21	MERCK & CO., INC. : Retroviruses and Opportunistic Infections Conference
03/04/21 \| 12:50pm	BIOMARIN PHARMACEUTICAL INC. : Cowen & Co. Health Care Conference
03/04/21 \| 12:50pm	AMGEN INC. : Cowen & Co. Health Care Conference

Previous year

Next Year

Annual results		2016	2017	2018	2019	2020	2021 (e)
Sales M $	Released Forecast Spread	9 674 9 605 0,72%	8 724 8 741 -0,19%	8 380 8 330 0,60%	8 601 8 572 0,34%	8 027 7 968 0,74%	8 678
Operating income (EBITDA) M $	Released Forecast Spread	4 305 4 266 0,92%	3 638 3 623 0,42%	3 474 3 416 1,7%	3 571 3 585 -0,38%	3 294 3 257 1,1%	3 449
Operating profit (EBIT) M $	Released Forecast Spread	4 013 3 987 0,65%	3 277 3 325 -1,4%	3 193 3 177 0,51%	3 226 3 304 -2,4%	2 959 3 003 -1,5%	3 148
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-2 435 -2 238 -8,8%	-1 741 -1 219 -43%	-4 154 -4 230 1,8%	-1 837 -423 -334%	-934 -577 -62%	226
Net income M $	Released Forecast Spread	-2 409 -2 151 -12%	2 404 1 579 52%	-4 148 -4 384 5,4%	-1 788 -333 -436%	-560 -529 -5,9%	14,3
EPS $	Released Forecast Spread	-6,94 -6,21 -12%	6,83 4,45 53%	-11,8 -12,4 4,7%	-5,08 -0,97 -422%	-1,58 -1,47 -7,5%	0,13
Announcement Date		02/28/2017	02/28/2018	02/20/2019	02/19/2020	02/24/2021

Previous period

Next period

Quarterly results		2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)	2022 Q1 (e)
Sales M $	Released Forecast Spread	2 136 2 087 2,4%	2 121 2 080 2,0%	2 016 2 029 -0,62%	2 152 2 151 0,05%	2 209 2 155 2,5%	2 224 2 197 1,2%	2 012 2 030 -0,89%	1 664 1 785 -6,8%	2 138 2 049 4,4%	2 213 2 175 1,8%	2 062	2 125	2 209	2 289	2 162
Operating income (EBITDA) M $	Released Forecast Spread	916 822 11%	858 824 4,1%	851 819 3,9%	880 894 -1,5%	942 890 5,9%	898 913 -1,6%	813 802 1,3%	622 730 -15%	948 847 12%	911 880 3,6%	819	812	901	949
Operating profit (EBIT) M $	Released Forecast Spread	848 773 9,6%	789 774 2,0%	775 744 4,2%	790 821 -3,8%	854 818 4,4%	807 846 -4,6%	754 733 2,9%	552 649 -15%	888 777 14%	813 816 -0,35%	734	771	824	839	748
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-300 -479 37%	-426 -379 -12%	-122 -414 71%	-179 -145 -23%	-66,0 -73,5 10%	-1 470 -56,1 -2 523%	-178 -123 -45%	-437 -205 -114%	75,0 -53,9 239%	-394 31,6 -1 345%	-14,0	40,1	61,6	127
Net income M $	Released Forecast Spread	-350 -560 38%	-344 -436 21%	-52,0 -428 88%	-171 -171 0,02%	-49,0 -90,1 46%	-1 516 -61,4 -2 370%	-152 -159 4,3%	-326 -202 -61%	71,0 -99,0 172%	-153 -80,0 -91%	-43,6	7,32	28,2	89,7
EPS $	Released Forecast Spread	-1,00 -1,58 37%	-0,98 -1,23 20%	-0,15 -1,21 88%	-0,49 -0,31 -60%	-0,14 -0,24 43%	-4,30 -0,19 -2 140%	-0,43 -0,38 -12%	-0,92 -0,52 -78%	0,20 -0,27 174%	-0,43 -0,23 -90%	-0,12	0,04	0,17	0,28
Announcement Date		11/06/2018	02/20/2019	05/06/2019	08/06/2019	11/04/2019	02/19/2020	05/07/2020	08/06/2020	11/03/2020	02/24/2021